Denali Therapeutics Inc. Common Stock (NASDAQ: DNLI) last traded at $24.92, down 0.12% on the session. The quote above updates while this page is open; the figures below are drawn from Denali Therapeutics Inc. Common Stock’s own filings and are restated only when a new one is published.
Denali Therapeutics Inc. Common Stock trades on NASDAQ under the ticker DNLI. Its market capitalisation is $3.98 billion.
Valuation measures for Denali Therapeutics Inc. Common Stock, derived from the latest quote and its most recent SEC filing.
| Market cap | $3.98B |
|---|---|
| Enterprise value | $4.10B |
| Price / book | 4.77 |
| Beta | 1.44 |
Trailing-twelve-month figures tagged in Denali Therapeutics Inc. Common Stock's XBRL filings with the SEC.
| Revenue (TTM) | $0.00 |
|---|---|
| Net income (TTM) | -$511.45M |
| EPS (TTM) | -$2.84 |
| Return on equity | -61.24% |
| Cash | $201.53M |
Range and volume for DNLI over the past 52 weeks.
| 52-week high | $27.30 |
|---|---|
| 52-week low | $12.58 |
| Volume | 681.0K |
| Average volume | 1.76M |
| Previous close | $24.95 |
A dash means FurlPay does not have that figure, not that it is zero. Nothing on this page is investment advice or a recommendation to buy or sell any security. Figures are provided for information only and may be delayed or restated.